Matches in Wikidata for { <http://www.wikidata.org/entity/Q65370376> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q65370376 description "clinical trial" @default.
- Q65370376 description "ensayu clínicu" @default.
- Q65370376 description "klinisch onderzoek" @default.
- Q65370376 description "клінічне випробування" @default.
- Q65370376 name "A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD)" @default.
- Q65370376 name "A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease" @default.
- Q65370376 type Item @default.
- Q65370376 label "A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD)" @default.
- Q65370376 label "A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease" @default.
- Q65370376 prefLabel "A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD)" @default.
- Q65370376 prefLabel "A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease" @default.
- Q65370376 P1132 Q65370376-4A1031F1-65F2-45D1-A5FD-02754B929EFF @default.
- Q65370376 P1476 Q65370376-02CBF43D-C8EE-41FA-8D0D-08FCDF604F30 @default.
- Q65370376 P17 Q65370376-044044E0-FB86-485F-B5EE-C0DB426485DD @default.
- Q65370376 P17 Q65370376-060663F8-8484-4D19-ADC0-763F64C15CEC @default.
- Q65370376 P17 Q65370376-4588A659-50AB-405A-B391-158FD0EC0748 @default.
- Q65370376 P17 Q65370376-7ECB9980-0E6A-4A98-84AA-FE619F3CEB4F @default.
- Q65370376 P17 Q65370376-C307AF4D-54AC-4AA6-BB3A-D9E2008195BF @default.
- Q65370376 P17 Q65370376-DBA1B263-A883-4BC4-BFBC-4FE703889F82 @default.
- Q65370376 P2899 Q65370376-39CAB7EE-D950-4B5C-80D6-DE3CD706BB0F @default.
- Q65370376 P3098 Q65370376-42C706E8-9696-4F5E-A644-AA238EF6DCD4 @default.
- Q65370376 P31 Q65370376-34382BFD-6E79-4C06-966A-9ADE94F682AA @default.
- Q65370376 P4844 Q65370376-1209A4C3-2803-4FEB-8D92-DFBE50AFD87F @default.
- Q65370376 P580 Q65370376-0798877B-FB14-4643-8318-B75DCCB3CBDF @default.
- Q65370376 P582 Q65370376-6794EB68-CF05-432D-ADC3-CFCB22EBD847 @default.
- Q65370376 P6099 Q65370376-F7E30B6A-CC97-4376-AE1E-B3D632E4D98E @default.
- Q65370376 P6153 Q65370376-33DFFD62-6B2E-48BB-B3E0-2CDE8125BBB7 @default.
- Q65370376 P8363 Q65370376-D2F63B16-B1E4-4EE5-A76D-679A00C9A5C4 @default.
- Q65370376 P859 Q65370376-F507F141-0243-4AFC-A668-67F471F0F21F @default.
- Q65370376 P921 Q65370376-FB1600FC-1C2C-4857-8E26-F8269F5E2649 @default.
- Q65370376 P1132 "+717" @default.
- Q65370376 P1476 "DB2116134: A Randomized, Multi-center, Double-blind, Double-dummy, Parallel Group Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With COPD" @default.
- Q65370376 P17 Q183 @default.
- Q65370376 P17 Q28 @default.
- Q65370376 P17 Q29 @default.
- Q65370376 P17 Q35 @default.
- Q65370376 P17 Q36 @default.
- Q65370376 P17 Q55 @default.
- Q65370376 P2899 "+40" @default.
- Q65370376 P3098 "NCT01822899" @default.
- Q65370376 P31 Q30612 @default.
- Q65370376 P4844 Q27264747 @default.
- Q65370376 P580 "2013-04-04T00:00:00Z" @default.
- Q65370376 P582 "2013-10-01T00:00:00Z" @default.
- Q65370376 P6099 Q42824827 @default.
- Q65370376 P6153 Q212322 @default.
- Q65370376 P8363 Q78089383 @default.
- Q65370376 P859 Q212322 @default.
- Q65370376 P921 Q199804 @default.